This inventor holds 22 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in HIV Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company, Viiv Healthcare UK (No. 4) Limited. Active years: 2005-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kennett Square, PA (US) (2005 - 2008)
- Middletown, CT (US) (2006 - 2020)
- Wallingford, CT (US) (2019 - 2021)
- Ewing, NJ (US) (2020 - 2024)
Company Filing History:
15 out of 3,745 
3 out of 234 
3 out of 8 
Years Active: 2005-2024
Areas of Expertise:
Title: Richard A. Hartz: Innovator in Pharmaceutical Chemistry
Introduction: Richard A. Hartz is a distinguished inventor based in Middletown, CT, USA, known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 22 patents, Hartz has made noteworthy advancements in the field, particularly in the development of compounds aimed at combating critical health issues.
Latest Patents: Among his notable inventions, two recent patents stand out. The first is for "Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors." This innovation focuses on compounds that inhibit Gal-3 and includes pharmaceutically acceptable salts, compositions that incorporate these compounds, and methods for their production and use. The second patent is titled "C-3 and C-17 modified triterpenoids as HIV-1 inhibitors," which details compounds displaying drug and bio-affecting properties. These compounds, specifically betulinic acid derivatives, show promise as HIV maturation inhibitors, beneficial for treating HIV and AIDS.
Career Highlights: Hartz has had a noteworthy career working for prominent pharmaceutical companies, including Bristol-Myers Squibb Company and ViiV Healthcare UK Limited. His work in these organizations has contributed significantly to the advancement of medical therapies aimed at serious diseases.
Collaborations: Throughout his career, Hartz has collaborated with talented professionals in his field, including notable coworkers Vijay T. Ahuja and Alicia Regueiro-Ren. These collaborations have likely enriched his work and facilitated the development of innovative solutions in healthcare.
Conclusion: Richard A. Hartz's contributions to pharmaceutical innovations exemplify how focused research and dedication can lead to meaningful advancements in medicine. His patents not only showcase his inventive capabilities but also highlight his commitment to addressing some of the most pressing health challenges facing society today.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile